Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/30/2002 | US20020065418 Viral polymerase inhibitors |
05/30/2002 | US20020065415 For treating cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, neurodegenerative disorders |
05/30/2002 | US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis |
05/30/2002 | US20020065307 Novel benzimidazole derivatives |
05/30/2002 | US20020065305 As antitumor agent |
05/30/2002 | US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
05/30/2002 | US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity |
05/30/2002 | US20020065270 For use in therapy of inflammatory diseases such as, for example, rheumatoid arthritis |
05/30/2002 | US20020064794 Modified carbocyanine dyes and their conjugates |
05/30/2002 | US20020064782 Fluorescent nucleotides |
05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
05/30/2002 | CA2428459A1 Novel compounds for use as hiv protease inhibitors |
05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
05/30/2002 | CA2427284A1 Antiinflammation agents |
05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
05/29/2002 | EP1208090A1 Herbicidaltetrazolinone derivatives |
05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
05/29/2002 | CN1351602A New pharmaceutically active compounds |
05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
05/29/2002 | CN1351595A Substituted polycyclic aryl and heteroacryl pyrazinones useful for selective inhibition of the coagulation cascade |
05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
05/29/2002 | CN1351590A Compounds |
05/29/2002 | CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors |
05/29/2002 | CN1350787A Synergistic herbicidal composition and method |
05/29/2002 | CN1350786A Synergistic herbicidal composition and method |
05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
05/28/2002 | US6395766 Cognition activators |
05/28/2002 | US6395764 Nosal decongestion, respiratory system disorders |
05/28/2002 | US6395753 Antihistamines, antiallergens, antiarthritic agents |
05/28/2002 | US6395734 Anticancer agents |
05/23/2002 | WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers |
05/23/2002 | WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy |
05/23/2002 | WO2002040473A1 Pyrimidine compounds or salts thereof, herbicides containing the compounds or the salts, methods for control of weeds by applying the same |
05/23/2002 | WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
05/23/2002 | WO2002040470A1 Imidazole derivatives, process for their preparation and their use |
05/23/2002 | WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
05/23/2002 | WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
05/23/2002 | WO2002008203A3 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
05/23/2002 | WO2001030330A3 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
05/23/2002 | WO2000063204A3 Substituted azoles |
05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
05/23/2002 | US20020061922 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
05/23/2002 | US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one |
05/23/2002 | US20020061917 Efficient process for the preparation of a factor Xa inhibitor |
05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
05/23/2002 | US20020061898 Inhibitors of nucleoside metabolism |
05/23/2002 | US20020061891 Indole derivatives as 5-HT1B and 5-HT1D agonists |
05/23/2002 | US20020061889 New pyridazine endothelin antagonists |
05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
05/23/2002 | DE10054019A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments |
05/23/2002 | CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds |
05/23/2002 | CA2429437A1 Imidazole derivatives, process for their preparation and their use |
05/23/2002 | CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
05/23/2002 | CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
05/22/2002 | EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
05/22/2002 | EP1206703A1 Use of acylsulfonamido-substituted polymethine dyes as fluorescence dyes and/or markers |
05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
05/22/2002 | EP0563238B1 Imidazolyl-alkenoic acids |
05/22/2002 | CN1350533A New ECE inhibitors, their production and their use |
05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
05/22/2002 | CN1350476A Novel triazine-based detoxification agents and their use |
05/22/2002 | CN1350458A Protease inhibitors |
05/22/2002 | CN1349983A Non-peptide neomatal vascularization inhibitor |
05/22/2002 | CN1085213C Triazole derivatives useful in therapy |
05/21/2002 | US6392046 Aids therapy |
05/21/2002 | US6391910 Opioid antagonist; analgesic |
05/21/2002 | US6391907 Anticancer agents; contraceptives |
05/21/2002 | US6391882 4,5,6 and 7-indole and indoline derivatitives, their preparation and use |
05/21/2002 | US6391874 Anticarcinogenic agents; skin disorders |
05/21/2002 | US6391064 Composition for hair dyeing comprising condensates of quinoline-5, 8-diones or of quinoxaline-5,8-diones and substituted pyrroles, anilines or indoles |
05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
05/16/2002 | WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
05/16/2002 | WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
05/16/2002 | WO2002038549A1 Hetero-anellated ortho-aminophenols and their use as dye components |
05/16/2002 | WO2002038544A2 3-substituted oxindole beta 3 agonists |
05/16/2002 | WO2002038543A2 3-substituted oxindole beta 3 agonists |
05/16/2002 | WO2002038184A1 Oral pharmaceutical composition containing a block copolymer |
05/16/2002 | WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds |
05/16/2002 | WO2002030890A8 Nitrogenous five-membered ring compounds |
05/16/2002 | WO2002018339A3 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
05/16/2002 | WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
05/16/2002 | WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments |
05/16/2002 | WO2001087287A3 Use of pyrazole derivatives for treating infertility |
05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
05/16/2002 | WO2001079198A9 Pyrazoles for inhibiting protein kinase |
05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
05/16/2002 | WO2001007434A3 Indole derivatives and their use as 5ht2a ligands |
05/16/2002 | US20020058816 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/ reproductive disorders, depression |
05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |